Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|January 17, 2003
Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokersJean-Charles Soria, Xiaochun Xu, Diane D Liu, et al.
Carcinogenesis|September 8, 2010
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerXiaofan Zhang, Hushan Yang, J Jack Lee, et al.
Carcinogenesis|June 8, 2004
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neckGuojun Li, Erich M Sturgis, Li-E Wang, et al.
Cancer|January 25, 2005
Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesisErminia Massarelli, Erika Brown, Ngoc K Tran, et al.
American Journal of Clinical Oncology|February 6, 2009
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumorsWilliam N William, Joseph L Lee, Dong M Shin, et al.
Carcinogenesis|July 15, 2010
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaJianming Wang, Scott M Lippman, J Jack Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 9, 2009
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsXifeng Wu, Margaret R Spitz, J Jack Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancerRalph G Zinner, Ritsuko Komaki, James D Cox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implicationShyh-Kuan Tai, Janet I Lee, K Kian Ang, et al.
Cancer|February 12, 2009
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancerEdward S Kim, Ann M Mauer, William N William, et al.
Pageof 7